JP2007531757A5 - - Google Patents

Download PDF

Info

Publication number
JP2007531757A5
JP2007531757A5 JP2007506511A JP2007506511A JP2007531757A5 JP 2007531757 A5 JP2007531757 A5 JP 2007531757A5 JP 2007506511 A JP2007506511 A JP 2007506511A JP 2007506511 A JP2007506511 A JP 2007506511A JP 2007531757 A5 JP2007531757 A5 JP 2007531757A5
Authority
JP
Japan
Prior art keywords
carboxamide
thiophene
pyrimidin
methylamino
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007506511A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007531757A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/010690 external-priority patent/WO2005095386A1/en
Publication of JP2007531757A publication Critical patent/JP2007531757A/ja
Publication of JP2007531757A5 publication Critical patent/JP2007531757A5/ja
Pending legal-status Critical Current

Links

JP2007506511A 2004-03-30 2005-03-30 抗癌剤としての置換チオフェン誘導体 Pending JP2007531757A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55834204P 2004-03-30 2004-03-30
PCT/US2005/010690 WO2005095386A1 (en) 2004-03-30 2005-03-30 Substituted thiophene derivatives as anti-cancer agents

Publications (2)

Publication Number Publication Date
JP2007531757A JP2007531757A (ja) 2007-11-08
JP2007531757A5 true JP2007531757A5 (cg-RX-API-DMAC7.html) 2008-04-17

Family

ID=34972501

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007506511A Pending JP2007531757A (ja) 2004-03-30 2005-03-30 抗癌剤としての置換チオフェン誘導体

Country Status (11)

Country Link
US (2) US7470701B2 (cg-RX-API-DMAC7.html)
EP (1) EP1732919A1 (cg-RX-API-DMAC7.html)
JP (1) JP2007531757A (cg-RX-API-DMAC7.html)
CN (1) CN1989131A (cg-RX-API-DMAC7.html)
AU (1) AU2005228899A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0508230A (cg-RX-API-DMAC7.html)
CA (1) CA2561977A1 (cg-RX-API-DMAC7.html)
IL (1) IL177799A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA06010520A (cg-RX-API-DMAC7.html)
RU (1) RU2006138036A (cg-RX-API-DMAC7.html)
WO (1) WO2005095386A1 (cg-RX-API-DMAC7.html)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8329924B2 (en) * 2001-06-11 2012-12-11 Vertex Pharmaceuticals (Canada) Incorporated Compounds and methods for the treatment or prevention of Flavivirus infections
EP2363396A1 (en) * 2001-06-11 2011-09-07 Virochem Pharma Inc. Thiophene derivatives as antiviral agents for flavivirus infection
DE60332482D1 (de) 2002-12-10 2010-06-17 Virochem Pharma Inc Verbindungen und methoden zum behandeln oder vorbeugen von flavivirus infektionen
TW200533357A (en) * 2004-01-08 2005-10-16 Millennium Pharm Inc 2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases
US20080293716A1 (en) * 2004-01-30 2008-11-27 Smithkline Beecham Corporation Chemical Compounds
WO2007018941A2 (en) * 2005-07-26 2007-02-15 Smithkline Beecham Corporation Pyrimidyl-thiophene derivatives
WO2007016292A2 (en) * 2005-07-27 2007-02-08 Vertex Pharmaceuticals Incorporated Heterocyclic amides as biofilm modulators
US7803806B2 (en) 2005-11-03 2010-09-28 Sgx Pharmaceuticals, Inc. Pyrimidinyl-thiophene kinase modulators
AU2007207743B2 (en) * 2006-01-18 2010-07-08 Amgen Inc. Thiazole compounds as protein kinase B (PKB) inhibitors
EP2474546A1 (en) 2006-01-23 2012-07-11 Vertex Pharmaceuticals Inc. Thiophene-carboxamides useful as inhibitors of protein kinases
ZA200808966B (en) 2006-03-27 2010-03-31 Nerviano Medical Sciences Srl Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
EP2007757B1 (en) 2006-04-13 2012-10-03 Vertex Pharmceuticals Incorporated Thiophene-carboxamides useful as inhibitors of protein kinases
JP2009538305A (ja) * 2006-05-23 2009-11-05 バーテックス ファーマシューティカルズ インコーポレイテッド プロテインキナーゼのインヒビターとして有用なチオフェンカルボキサミド
CA2652816A1 (en) * 2006-05-23 2007-12-06 Vertex Pharmaceuticals Incorporated Thiophene-carboxamides useful as inhibitors of protein kinases
SG176488A1 (en) * 2006-11-15 2011-12-29 Virochem Pharma Inc Thiophene analogues for the treatment or prevention of flavivirus infections
UY30892A1 (es) 2007-02-07 2008-09-02 Smithkline Beckman Corp Inhibidores de la actividad akt
AU2012233017B2 (en) * 2007-02-07 2013-01-10 Novartis Ag Inhibitors of Akt activity
WO2008098105A1 (en) * 2007-02-07 2008-08-14 Smithkline Beecham Corporation Inhibitors of akt activity
DE102007010801A1 (de) 2007-03-02 2008-09-04 Bayer Cropscience Ag Diaminopyrimidine als Fungizide
US7897619B2 (en) 2007-07-17 2011-03-01 Amgen Inc. Heterocyclic modulators of PKB
US7919504B2 (en) * 2007-07-17 2011-04-05 Amgen Inc. Thiadiazole modulators of PKB
CN101711245B (zh) * 2007-07-19 2015-03-25 H.隆德贝克有限公司 5元杂环酰胺及相关的化合物
BRPI0818533B8 (pt) * 2007-10-11 2021-05-25 Astrazeneca Ab composto, composição farmacêutica, uso de um composto, e, processo para a preparação de um composto
WO2009094224A1 (en) 2008-01-25 2009-07-30 Millennium Pharmaceuticals, Inc. Thiophenes and their use as phosphatidylinositol 3-kinase (pi3k) inhibitors
TWI426074B (zh) * 2008-04-30 2014-02-11 Nerviano Medical Sciences Srl 5-(2-胺基-嘧啶-4-基)-2-芳基-1h-吡咯-3-羧醯胺之製造方法
US20110098221A1 (en) * 2008-06-26 2011-04-28 Hong Lin INHIBITORS OF Akt ACTIVITY
WO2009158374A2 (en) * 2008-06-26 2009-12-30 Smithkline Beecham Corporation Inhibitors of akt activity
EP2161259A1 (de) 2008-09-03 2010-03-10 Bayer CropScience AG 4-Halogenalkylsubstituierte Diaminopyrimidine als Fungizide
NZ594064A (en) 2009-01-30 2012-08-31 Glaxosmithkline Llc Crystalline n-{ (1s)-2-amino-1-[(3-fluorophenyl)methyl]ethyl} -5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
US9090601B2 (en) 2009-01-30 2015-07-28 Millennium Pharmaceuticals, Inc. Thiazole derivatives
JP2012516329A (ja) 2009-01-30 2012-07-19 ミレニアム ファーマシューティカルズ, インコーポレイテッド Pi3k阻害剤としてのヘテロアリールおよびその使用
US8796314B2 (en) 2009-01-30 2014-08-05 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
WO2010101302A1 (en) 2009-03-05 2010-09-10 Takeda Pharmaceutical Company Limited Thienopyrimidine as cdc7 kinase inhibitors
KR20120051022A (ko) * 2009-07-21 2012-05-21 길리애드 사이언시즈, 인코포레이티드 플라비비리데 바이러스의억제제
CA2771124C (en) 2009-09-09 2019-01-15 Gilead Sciences, Inc. Inhibitors of flaviviridae viruses
EA201290575A1 (ru) 2010-01-15 2013-01-30 Джилид Сайэнс, Инк. Ингибиторы вирусов flaviviridae
TWI491609B (zh) 2010-01-15 2015-07-11 Gilead Sciences Inc 黃熱病毒科(Flaviviridae)病毒之抑制劑類
EP3533797B1 (en) 2010-02-17 2023-12-20 Takeda Pharmaceutical Company Limited Heterocyclic compound
EP2603214A4 (en) 2010-08-11 2013-12-18 Millennium Pharm Inc HETEROARYLE AND USES THEREOF
US8859768B2 (en) 2010-08-11 2014-10-14 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
US9062038B2 (en) 2010-08-11 2015-06-23 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
MX2013004003A (es) 2010-10-13 2013-10-01 Millenium Pharmaceuticals Inc Heteroarilos y usos de los mismos.
US8741946B2 (en) 2011-07-13 2014-06-03 Gilead Sciences, Inc. Inhibitors of flaviviridae viruses
TWI490221B (zh) * 2011-08-15 2015-07-01 武田藥品工業股份有限公司 雜環化合物
ES2617379T3 (es) * 2012-04-13 2017-06-16 Epizyme, Inc. Forma de sal de un inhibidor de histona metiltransferasa EZH2 humana
JPWO2013161871A1 (ja) * 2012-04-25 2015-12-24 興和株式会社 Tlr阻害作用を有するチオフェン誘導体
US8927741B2 (en) 2012-08-17 2015-01-06 Gilead Sciences, Inc. Synthesis of an antiviral compound
US8759544B2 (en) 2012-08-17 2014-06-24 Gilead Sciences, Inc. Synthesis of an antiviral compound
US8841340B2 (en) 2012-08-17 2014-09-23 Gilead Sciences, Inc. Solid forms of an antiviral compound
HK1214815A1 (zh) * 2013-04-30 2016-08-05 Glaxosmithkline Intellectual Property (No. 2) Limited Zeste增强子同源物2的抑制剂
CN104262289B (zh) * 2014-10-09 2016-06-08 武汉大学 一种苯并噻唑衍生物及其抗肿瘤用途
HUE057041T2 (hu) 2015-07-06 2022-04-28 Alkermes Inc Hiszton deacetiláz hetero-halogén gátlói
WO2017007755A1 (en) 2015-07-06 2017-01-12 Rodin Therapeutics, Inc. Heterobicyclic n-aminophenyl-amides as inhibitors of histone deacetylase
ES2911888T3 (es) * 2015-09-18 2022-05-23 Merck Patent Gmbh Compuestos de heteroarilo como inhibidores de IRAK y usos de los mismos
WO2017063966A1 (en) * 2015-10-13 2017-04-20 Bayer Pharma Aktiengesellschaft Substituted 2-(1h-pyrazol-1-yl)-benzothiazole compounds
CN107056755B (zh) * 2015-12-07 2019-02-22 苏州信诺维医药科技有限公司 五元杂环酰胺类wnt通路抑制剂
CN108884066B (zh) 2016-02-16 2021-08-24 韩国科学技术研究院 作为蛋白激酶抑制剂的2,3,5-取代的噻吩化合物
HRP20220223T1 (hr) 2017-01-11 2022-04-29 Alkermes, Inc. Biciklički inhibitori histon deacetilaze
GB201712567D0 (en) 2017-08-04 2017-09-20 Karin & Sten Mortstedt Cbd Solutions Ab Selective ligands for tau aggregates
US11225475B2 (en) 2017-08-07 2022-01-18 Alkermes, Inc. Substituted pyridines as inhibitors of histone deacetylase
GB201807147D0 (en) 2018-05-01 2018-06-13 Oncologica Uk Ltd Therapeutic combination
CN109400595B (zh) * 2018-12-24 2020-07-17 深圳市第二人民医院 一类含噻吩环的抗癌化合物
AU2020228307A1 (en) * 2019-02-28 2021-09-23 Kezar Life Sciences Thiazole derivatives as protein secretion inhibitors
US20220389026A1 (en) * 2019-08-20 2022-12-08 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Tetracyclic compound used as cdc7 inhibitor
CN115536648B (zh) * 2021-06-29 2024-09-17 深圳开悦生命科技有限公司 一类抑制rna解旋酶dhx33的多环化合物及其应用
CN114644582B (zh) * 2022-04-11 2024-03-29 中原工学院 一种苯基双硫脲类化合物的制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3908012A (en) * 1970-10-05 1975-09-23 Pfizer Arylpyrimidines-inhibitors of platelet aggregation and bronchodilators
US5731315A (en) * 1995-06-07 1998-03-24 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted sulfonic acid n- (aminoiminomethyl)phenylalkyl!-azaheterocyclamide compounds
US6034093A (en) * 1995-06-07 2000-03-07 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds
US6080767A (en) * 1996-01-02 2000-06-27 Aventis Pharmaceuticals Products Inc. Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
US6399656B1 (en) * 1998-07-28 2002-06-04 Smithkline Beecham Corporation Compounds and methods
WO2000075129A1 (en) 1999-06-07 2000-12-14 Shire Biochem Inc. Thiophene integrin inhibitors
YU63802A (sh) 2000-02-25 2005-06-10 F. Hoffmann-La Roche Ag. Modulatori adenozinskih receptora
JP2002037784A (ja) * 2000-05-17 2002-02-06 Nikken Chem Co Ltd 新規チオフェンアミド化合物
DE10034623A1 (de) * 2000-07-17 2002-01-31 Bayer Ag Heterocyclisch substituierte Pyridine als Cytokin-Inhibitoren
DE60214701T2 (de) * 2001-04-13 2007-09-13 Vertex Pharmaceuticals Inc., Cambridge Inhibitoren von c-jun-n-terminalen-kinasen (jnk) und anderen proteinkinasen
SE0102439D0 (sv) 2001-07-05 2001-07-05 Astrazeneca Ab New compounds
FR2827603B1 (fr) * 2001-07-18 2003-10-17 Oreal Composes derives de diaminopyrazole substitues par un radical heteroaromatique et leur utilisation en teinture d'oxydation des fibres keratiniques
US6897220B2 (en) * 2001-09-14 2005-05-24 Methylgene, Inc. Inhibitors of histone deacetylase
AU2002356871A1 (en) * 2001-10-30 2003-05-12 Pharmacia Corporation Heteroaromatic carboxamide derivatives for the treatment of inflammation
WO2003086279A2 (en) * 2002-04-08 2003-10-23 Merck & Co., Inc. Inhibitors of akt activity
GB0209715D0 (en) * 2002-04-27 2002-06-05 Astrazeneca Ab Chemical compounds
US7119111B2 (en) * 2002-05-29 2006-10-10 Amgen, Inc. 2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use
GB0215650D0 (en) * 2002-07-05 2002-08-14 Cyclacel Ltd Bisarylsufonamide compounds
KR20050034732A (ko) * 2002-08-02 2005-04-14 아젠터 디스커버리 리미티드 히스톤 디아세틸라제 억제제로서의 치환된티에닐-히드록사믹산
AU2003288956A1 (en) * 2002-10-30 2004-06-07 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of rock and other protein kinases
PT2476667E (pt) * 2003-02-26 2014-09-18 Sugen Inc Compostos de aminoheteroarilo como inibidores da proteína quinase
GB0308466D0 (en) * 2003-04-11 2003-05-21 Novartis Ag Organic compounds
TW200533357A (en) * 2004-01-08 2005-10-16 Millennium Pharm Inc 2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases
US20080293716A1 (en) * 2004-01-30 2008-11-27 Smithkline Beecham Corporation Chemical Compounds

Similar Documents

Publication Publication Date Title
RU2006138036A (ru) Производные замещенного тиофена в качестве противораковых средств
AU2005316312B2 (en) Aminopyrimidine compounds and methods of use
JP2006503081A5 (cg-RX-API-DMAC7.html)
RU2009149696A (ru) 5-замещенные индазолы в качестве ингибиторов киназы
JP2017538750A5 (cg-RX-API-DMAC7.html)
RU2007117913A (ru) 2, 6-замещенные-4-монозамещенный амино-пиримидины как антагонисты рецептора простагландина d2
RU2010137300A (ru) Модуляторы бета-амилоида
RU2019117958A (ru) Производные индола, полезные в качестве ингибиторов диацилглицерид-о-ацилтрансферазы 2
RU2010137114A (ru) Амидные производные как позитивные аллостерические модуляторы и способы их применения
JP2007516173A5 (cg-RX-API-DMAC7.html)
HRP20211960T1 (hr) Alosterični modulatori nikotinskih acetilcolinskih receptora
RU2017125520A (ru) Соединения, ингибирующие parg
RU2017139727A (ru) Гетероциклические ингибиторы erk1 и erk2 и их применение для лечения злокачественного новообразования
RU2008141510A (ru) Новые соединения
RU2006145205A (ru) Терапевтические соединения: пиридин в качестве каркаса
ME00681B (me) Jedinjenje indola
JP2013516415A5 (cg-RX-API-DMAC7.html)
JP2004509952A5 (cg-RX-API-DMAC7.html)
JP2005527625A5 (cg-RX-API-DMAC7.html)
JP2013538801A5 (cg-RX-API-DMAC7.html)
RU2007143966A (ru) Конденсированные гетероциклические соединения
RU2011103789A (ru) Производное триазола или его соль
JP2010540462A5 (cg-RX-API-DMAC7.html)
JP2020529998A5 (cg-RX-API-DMAC7.html)
JP2020512401A5 (cg-RX-API-DMAC7.html)